{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:59:03Z","timestamp":1793404743746,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T00:00:00Z","timestamp":1540080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005075","name":"University Medical Center Groningen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00259-018-4192-z","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T19:54:53Z","timestamp":1540065293000},"page":"174-183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Role of FDG PET\/CT in monitoring treatment response in patients with invasive fungal infections"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1213-3949","authenticated-orcid":false,"given":"Alfred O.","family":"Ankrah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert F. R.","family":"Span","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans C.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim A.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi A. J. O.","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike M.","family":"Sathekge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andor W. J. M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,21]]},"reference":[{"key":"4192_CR1","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17:e383\u201392.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"4192_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2174\/1381612824666171213101648","volume":"24","author":"AO Ankrah","year":"2018","unstructured":"Ankrah AO, Klein HC, Span LFR, de Vries EFJ, Dierckx RAJO, Sathekge MM, et al. The role of PET in monitoring therapy in fungal infections. Curr Pharm Des. 2018;24(7):795\u2013805.","journal-title":"Curr Pharm Des"},{"key":"4192_CR3","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1016\/S1473-3099(17)30304-3","volume":"17","author":"AL Colombo","year":"2017","unstructured":"Colombo AL, de Almeida J\u00fanior JN, Slavin MA, Chen SC, Sorrell TC. Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer. Lancet Infect Dis. 2017;17:e344\u201356.","journal-title":"Lancet Infect Dis"},{"key":"4192_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40336-015-0159-2","volume":"4","author":"AO Ankrah","year":"2016","unstructured":"Ankrah AO, Sathekge MM, Dierckx RA, Glaudemans AW. Imaging fungal infections in children. Clin Transl Imaging. 2016;4:57\u201372.","journal-title":"Clin Transl Imaging"},{"key":"4192_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00062-014-0305-7","volume":"24","author":"J Starkey","year":"2014","unstructured":"Starkey J, Moritani T, Kirby P. MRI of CNS fungal infections: review of aspergillosis to histoplasmosis and everything in between. Clin Neuroradiol. 2014;24:217\u201330.","journal-title":"Clin Neuroradiol"},{"issue":"S1","key":"4192_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, et al. Diagnosis and management of aspergillus diseases: executive summary of the 2017 ESCMID\u2013ECMM\u2013ERS guideline. Clin Microbiol Infect. 2018;24(S1):e1\u2013e38.","journal-title":"Clin Microbiol Infect"},{"key":"4192_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1053\/j.semnuclmed.2017.10.004","volume":"48","author":"MM Sathekge","year":"2018","unstructured":"Sathekge MM, Ankrah AO, Lawal I, Vorster M. Monitoring response to therapy. Semin Nucl Med. 2018;48:166\u201381.","journal-title":"Semin Nucl Med"},{"key":"4192_CR8","doi-asserted-by":"publisher","first-page":"20170508","DOI":"10.1259\/bjr.20170508","volume":"91","author":"H Zaidi","year":"2018","unstructured":"Zaidi H, Karakatsanis N. Towards enhanced PET quantification in clinical oncology. Br J Radiol. 2018;91:20170508.","journal-title":"Br J Radiol"},{"key":"4192_CR9","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1007\/s00259-014-2803-x","volume":"41","author":"JW Lee","year":"2014","unstructured":"Lee JW, Cho A, Lee JH, Yun M, Lee JD, Kim YT, et al. The role of metabolic tumor volume and total lesion glycolysis on 18F-FDG PET\/CT in the prognosis of epithelial ovarian cancer. Eur J Nucl Med Mol Imaging. 2014;41:1898\u2013906.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4192_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00259-017-3836-8","volume":"45","author":"KR Kim","year":"2018","unstructured":"Kim KR, Shim HJ, Hwang JE, Cho SH, Chung IJ, Park KS, et al. The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer. Eur J Nucl Med Mol Imaging. 2018;45:170\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4192_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3109\/14397595.2014.990674","volume":"25","author":"Y Nakatsuka","year":"2015","unstructured":"Nakatsuka Y, Handa T, Nakamoto Y, Nobashi T, Yoshihuji H, Tanizawa K, et al. Total lesion glycolysis as an IgG4-related disease activity marker. Mod Rheumatol. 2015;25:579\u201384.","journal-title":"Mod Rheumatol"},{"key":"4192_CR12","doi-asserted-by":"publisher","first-page":"e7130","DOI":"10.1097\/MD.0000000000007130","volume":"96","author":"A Bhattarai","year":"2017","unstructured":"Bhattarai A, Nakajima T, Sapkota S, Arisaka Y, Tokue A, Yonemoto Y, et al. Diagnostic value of 18F-fluorodeoxyglucose uptake parameters to differentiate rheumatoid arthritis from other types of arthritis. Medicine (Baltimore). 2017;96:e7130.","journal-title":"Medicine (Baltimore)"},{"key":"4192_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4192_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1469-0691.2010.03301.x","volume":"17","author":"A Hot","year":"2011","unstructured":"Hot A, Maunoury C, Poiree S, Lanternier F, Viard JP, Loulergue P, et al. Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect. 2011;17:409\u201317.","journal-title":"Clin Microbiol Infect"},{"key":"4192_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/nm.4177","volume":"22","author":"ST Malherbe","year":"2016","unstructured":"Malherbe ST, Shenai S, Ronacher K, Loxton AG, Dolganov G, Kriel M, et al. Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure. Nat Med. 2016;22:1094\u2013100.","journal-title":"Nat Med"},{"key":"4192_CR16","doi-asserted-by":"publisher","unstructured":"Douglas AP, Thursky KA, Worth LJ, Drummond E, Hogg A, Hicks RJ, et al. FDG PET\/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging. Eur J Nucl Med Mol Imaging. 2018. \n                    https:\/\/doi.org\/10.1007\/s00259-018-4062-8\n                    \n                  .","DOI":"10.1007\/s00259-018-4062-8"},{"key":"4192_CR17","doi-asserted-by":"crossref","unstructured":"Leroy-Freschini B, Treglia G, Argemi X, Bund C, Kessler R, Herbrecht R, et al. 18F-FDG PET\/CT for invasive fungal infection in immunocompromised patients. Q J Med. 2018;111:613\u201322.","DOI":"10.1093\/qjmed\/hcy128"},{"key":"4192_CR18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/1469-0691.12426","volume":"19","author":"S Leroux","year":"2013","unstructured":"Leroux S, Ullmann AJ. Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal. Clin Microbiol Infect. 2013;19:1115\u201321.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"4192_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1080\/14712598.2017.1322576","volume":"17","author":"Wilfried Posch","year":"2017","unstructured":"Posch W, Steger M, Wilflingseder D, Lass-Fl\u00f6rl C. Promising immunotherapy against fungal diseases. Expert Opin Biol Ther. 2017;17:861\u201370.","journal-title":"Expert Opinion on Biological Therapy"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4192-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4192-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4192-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T21:32:36Z","timestamp":1571607156000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4192-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,21]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4192"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4192-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,21]]},"assertion":[{"value":"16 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}